Regime: STAGFLATION INTENSIFYING. VOO $622.00 (RSI 43, -2.3% 30D). QQQM $250.24 (RSI 49) outperforming. VIXY $32.68 (RSI 62, +24.5% 30D) -- fear elevated but easing slightly (-4.1% 7D). GLD $476.25 (RSI 56, +21.1% 3M) structural safe haven. Oil parabolic: USO RSI 81, +36.8% 30D, +55.9% 3M. Housing in capitulation: ITB RSI 27, XHB RSI 29. Life sciences tools in coordinated selloff: DHR RSI 29, MDT RSI 27, TMO RSI 33. Zero golden signals for second consecutive scan. 49 of 59 insider-tracked stocks show net selling.
1. Market Weather
| Indicator |
Level |
RSI |
30D Chg |
Signal |
Note |
| VOO (S&P 500) |
$622.00 |
43 |
-2.3% |
Slow bleed |
Below SMA20 ($629). Weak-down trend. |
| QQQM (Nasdaq) |
$250.24 |
49 |
-0.9% |
Outperforming |
At SMA20. Tech = new defensive. QQQ > VOO widens. |
| VIXY (VIX) |
$32.68 |
62 |
+24.5% |
FEAR ELEVATED |
Down -4.1% 7D (slight easing) but still +24.5% 30D. No all-clear. |
| GLD (Gold) |
$476.25 |
56 |
+1.8% |
Safe haven |
+21.1% 3M. Structural uptrend. Above all SMAs. |
| TLT (Bonds) |
$88.28 |
46 |
+0.6% |
Neutral |
Above SMA50. Orderly. Not surging. |
| EEM (EM) |
$58.68 |
45 |
-4.7% |
Fading |
Pulled back from overbought. Oil/dollar pain for importers. |
| USO (Oil) |
$107.93 |
81 |
+36.8% |
PARABOLIC |
Iran/Hormuz crisis. +55.9% 3M. Do NOT chase. |
One-liner: Stagflation is the word. Oil parabolic (USO RSI 81) is crushing housing (ITB RSI 27), life sciences (DHR RSI 29), and consumer discretionary (XLY RSI 39). Gold works, QQQ > VOO, and VIXY is slightly easing (-4.1% 7D) but still elevated. Portfolio gave back gains -- CRSP reversed -11.6% in one week, INTU pulled back from +21.5% to +13%. Two new buys (DHR, LOW) add quality at oversold levels.
2. Sector Heat Map
Overbought (Don't Chase)
| Sector |
Ticker/ETF |
RSI |
30D Chg |
Signal |
| Oil / Energy |
USO |
81 |
+36.8% |
PARABOLIC -- Iran/Hormuz. Do NOT chase. |
| Energy Equities |
XLE |
60 |
+1.1% |
Strong-up, +22% 3M. Consolidating. |
| Dollar |
UUP |
66 |
+2.3% |
Strong-up. Flight to USD amplifying EM/oil importer pain. |
| Utilities |
XLU |
58 |
+4.4% |
Strong-up, +9% 3M. Defensive rotation. |
| Gold / Safe Haven |
GLD |
56 |
+1.8% |
Structural bid, +21.1% 3M. |
Oversold (Opportunity Zone)
| Sector |
Ticker/ETF |
RSI |
30D Chg |
Signal |
| Homebuilders |
ITB |
27 |
-14.1% |
CAPITULATION. Housing implosion from oil shock. |
| Homebuilders |
XHB |
29 |
-13.5% |
Same thesis. Needs oil reversal catalyst. |
| Financials |
XLF |
35 |
-5.1% |
Down trend. Below SMA200. |
| Materials |
XLB |
38 |
-7.0% |
Weak-down. Copper dragging (COPX -7.8% 30D). |
| Consumer Discretionary |
XLY |
39 |
-2.8% |
Down trend. NKE RSI 29, LULU RSI 34. |
| Life Sciences Tools |
DHR/MDT/TMO |
27-33 |
-6 to -11% |
Coordinated sector de-rating. Rare. |
Recovering / Neutral
| Sector |
Status |
| Cloud/SaaS |
V-shape FADED. 14 death crosses. WDAY $142, SNOW $179. Structural repricing, not a dip. |
| Big Tech |
MSFT $405 (RSI 56), GOOGL $309 (RSI 47), AMZN $213 (RSI 47). Holding. |
| Semis |
SMH RSI 48. AVGO +8.8%. Neutral. |
| Biotech |
XBI RSI 54. CRSP reversed -11.6% 7D to $49.94. LEGN +13.7%. |
| Communication |
XLC RSI 52. Only sector above SMA20. |
3. Top 5 Opportunities
| Rank |
Ticker |
Price |
RSI |
Entry Zone |
Conviction |
Why |
| 1 |
DHR |
$195.22 |
29 |
$185-$200 |
Strong Buy |
Life sciences bellwether at rare RSI 29. Quality compounder -15.9% 3M. When DHR hits this RSI, historically strong entry. BOUGHT TODAY. |
| 2 |
LOW |
$246.81 |
30 |
$240-$250 |
Strong Buy |
Golden cross INTACT -- only quality bargain with unbroken long-term trend. Testing SMA200. Housing franchise. BOUGHT TODAY. |
| 3 |
BNTX |
$83.89 |
23 |
$75-$85 |
Research |
mRNA capitulation. -23.3% 30D. MRNA +89% 3M divergence is extreme. Needs pipeline research. |
| 4 |
MDT |
$89.89 |
27 |
$85-$92 |
Strong Buy |
Defensive medtech rarely sub-30 RSI. Life sciences tools selloff. HELD POSITION. 8.3% from stop. |
| 5 |
ASAN |
$7.07 |
34 |
$6.50-$7.50 |
Accumulate |
ONLY bargain-bin stock with insider buying (+$8.3M). Closest to golden signal. |
DHR and LOW were the two actionable Strong Buys today. BNTX needs research before entry. MDT in holdings approaching stop.
4. Top Risks
Stop-Loss Proximity (Paper Portfolios)
| Stock |
Strategy |
Entry |
Stop |
Current |
Distance |
Status |
| TMO |
claude-trader |
$544.19 |
$462.56 (-15%) |
$495.61 |
7.1% above |
CLOSEST -- life sciences selloff + insider selling -$310M |
| LULU |
claude-trader |
$177.34 |
$150.74 (-15%) |
$162.83 |
8.0% above |
WORSENED from 10.4% -- death cross, RSI 34 |
| ORCL |
claude-momentum |
$152.95 |
$137.66 (-10%) |
$149.40 |
8.5% above |
Continued drift lower. Weak RSI 43. |
| CRSP |
claude-trader |
$51.31 |
$43.61 (-15%) |
$49.94 |
14.5% above |
REVERSED HARD -- was +14.6%, now -2.7% |
bench-signals Danger Zone
| Stock |
Entry |
Current |
Unrealized |
Status |
| ESTC |
$59.00 |
$51.85 |
-12.1% |
3.3% from -15% stop. DANGER. |
| PINS |
$22.00 |
$19.37 |
-12.0% |
Approaching -15% stop. DANGER. |
| NKE |
$61.00 |
$55.72 |
-8.7% |
Death cross, RSI 29. Turnaround under max stress. |
| TMO |
$542.36 |
$495.61 |
-8.6% |
Life sciences tools selloff. Watch. |
| AS |
$36.00 |
$33.28 |
-7.6% |
RSI 32, -16.4% 30D. Accelerating selloff. |
Real Portfolio Alerts
| Stock |
Alert |
Status |
| MDT |
$83 stop (-15%) |
WARNING -- RSI 27, 8.3% from stop. Life sciences tools selloff. |
| AS |
$30.71 stop (-15%) |
WARNING -- RSI 32, 8.4% from stop. -16.4% 30D. DO NOT ADD. |
| NET |
$180 stop (raised) |
SAFE -- $212.44. +19.8%. Consider partial at $231 (+30% target). |
| BTC/GBTC |
Hold |
DEEP UNDERWATER -- $31.25 (-22.0%). Small allocation. |
| AMZN |
Watch |
Death cross formed (SMA50 crossed below SMA200). Unusual for Mag7. |
5. Actions Log
Trades Executed 03/11
| Strategy |
Trade |
Ticker |
Price |
Shares |
Value |
Rationale |
| claude-trader |
BUY |
DHR |
$195.22 |
12 |
$2,343 |
Life sciences bellwether RSI 29. Quality compounder. Strong Buy. |
| claude-trader |
BUY |
LOW |
$246.81 |
10 |
$2,468 |
Golden cross intact, RSI 30. Testing SMA200. Strong Buy. |
| claude-momentum |
BUY |
LOW |
$246.81 |
16 |
$3,949 |
RSI 30, only quality oversold with golden cross. |
| bench-signals |
SELL |
AFRM |
$49.77 |
16.1 |
$801 |
-19.7% stop-loss hit. Fintech crushed in stagflation. |
| bench-signals |
SELL |
NFLX |
$96.94 |
12.4 |
$1,202 |
+20.0% WIN target hit. FIRST WINNER! |
| bench-signals |
BUY |
MDT |
$89.89 |
11.1 |
$1,000 |
RSI 27, defensive medtech. Life sciences tools selloff. |
| bench-signals |
BUY |
DHR |
$195.22 |
5.1 |
$1,000 |
RSI 29, quality compounder. Life sciences bellwether. |
| yolo |
HOLD |
-- |
-- |
-- |
-- |
No trades. Stagflation regime too hostile for new YOLO entries. |
New Entry Zones (vs 03/10)
| Ticker |
RSI |
Entry Zone |
Change |
| BNTX |
23 |
$75-$85 |
NEW -- mRNA capitulation, needs research |
| DHR |
29 |
$185-$200 |
NEW -- life sciences tools bellwether. BOUGHT. |
| ITB |
27 |
$93-$97 |
NEW -- housing capitulation |
| XHB |
29 |
$100-$105 |
NEW -- homebuilders capitulation |
| MDT |
27 |
$85-$92 |
NEW -- defensive medtech |
| VMC |
30 |
$265-$275 |
NEW -- aggregates infrastructure |
| ISRG |
40 |
<$480 |
NEW ALERT -- watch for sub-$475 |
| RKLB |
49 |
<$70 |
NEW ALERT -- best structural pullback setup |
Profit Target / Stop Events 03/11
| Stock |
Strategy |
Entry |
Exit |
Gain/Loss |
Reason |
| NFLX |
bench-signals |
$80.78 |
$96.94 |
+20.0% WIN |
First winner! Held 28 days. RSI 68 overbought -- mechanical exit. |
| AFRM |
bench-signals |
$61.99 |
$49.77 |
-19.7% LOSS |
Blew through -15% stop. Fintech crushed in stagflation. 5th loss. |
6. Portfolio Pulse
Leaderboard
| Rank |
Strategy |
Return |
Value |
Cash |
Positions |
Trades Today |
Trend |
| 1 |
claude-trader |
+2.81% |
$102,807 |
$55,335 (54%) |
21 |
2 (BUY DHR, LOW) |
DOWN (was +3.12%) |
| 2 |
bench-signals |
-0.2% open / -1.9% net |
~$45,104 on $46K |
-- |
46 open / 6 closed |
4 (sold AFRM/NFLX, bought MDT/DHR) |
DOWN (was +1.8%) |
| 3 |
claude-momentum |
-0.11% |
$99,886 |
$71,481 (72%) |
8 |
1 (BUY LOW) |
DOWN (was -0.15%) |
| 4 |
yolo |
-0.81% |
$99,191 |
$45,833 (46%) |
7 |
0 (HOLD) |
DOWN (was -0.33%) |
Overall: Stagflation pullback hit all strategies. Claude-trader remains leader at +2.81% but slipped from +3.12%. CRSP reversed hard (-11.6% 7D, from +14.6% to -2.7%), dragging YOLO and trader. Bench-signals got its FIRST WINNER (NFLX +20.0%) but also its 5th loss (AFRM -19.7%). Net realized for bench-signals: 1W/5L, -$800. YOLO went from near-breakeven to -0.81% as CRSP/WDAY/ORCL gave back gains.
claude-trader Positions (21) -- $102,807 (+2.81%)
| Stock |
Shares |
Entry |
Current |
P&L |
% |
Status |
| NFLX |
24 |
$80.78 |
$96.94 |
+$388 |
+20.0% |
LEADER -- approaching +30% target |
| INTU |
10 |
$389.98 |
$440.65 |
+$507 |
+13.0% |
Pulled back from +21.5%. Death cross. |
| NOW |
19 |
$102.63 |
$115.61 |
+$247 |
+12.6% |
Surged from +4.8%. Best weekly gainer. |
| AVGO |
9 |
$313.78 |
$341.50 |
+$249 |
+8.8% |
AI ASIC thesis intact |
| SNOW |
12 |
$170.57 |
$179.11 |
+$102 |
+5.0% |
Pulled back slightly |
| MSFT |
5 |
$390.00 |
$404.75 |
+$74 |
+3.8% |
Steady |
| WCLD |
70 |
$27.88 |
$28.82 |
+$66 |
+3.4% |
Cloud ETF |
| WDAY |
21 |
$138.57 |
$142.47 |
+$82 |
+2.8% |
SaaS repricing risk |
| ISRG |
4 |
$476.32 |
$485.85 |
+$38 |
+2.0% |
Holding |
| ADBE |
7 |
$269.39 |
$273.75 |
+$31 |
+1.6% |
|
| AMZN |
9 |
$210.10 |
$212.65 |
+$23 |
+1.2% |
AMZN death cross formed |
| GOOGL |
6 |
$305.72 |
$308.85 |
+$19 |
+1.0% |
|
| IGV |
25 |
$85.02 |
$85.72 |
+$18 |
+0.8% |
|
| CLX |
22 |
$115.50 |
$115.87 |
+$8 |
+0.3% |
Defensive |
| CRM |
10 |
$193.75 |
$193.96 |
+$2 |
+0.1% |
Flat |
| DHR |
12 |
$195.22 |
$195.22 |
$0 |
0.0% |
NEW today |
| LOW |
10 |
$246.81 |
$246.81 |
$0 |
0.0% |
NEW today |
| ORCL |
13 |
$152.95 |
$149.40 |
-$46 |
-2.3% |
Below entry, weak |
| CRSP |
40 |
$51.31 |
$49.94 |
-$55 |
-2.7% |
REVERSED from +14.6% |
| LULU |
11 |
$177.34 |
$162.83 |
-$160 |
-8.2% |
8.0% above stop |
| TMO |
3 |
$544.19 |
$495.61 |
-$146 |
-8.9% |
7.1% above stop -- CLOSEST |
claude-momentum Positions (8) -- $99,886 (-0.11%)
| Stock |
Shares |
Entry |
Current |
P&L |
% |
Status |
| SNOW |
19 |
$156.71 |
$179.11 |
+$426 |
+14.3% |
5% from +20% target |
| AVGO |
15 |
$313.84 |
$341.50 |
+$415 |
+8.8% |
AI ASIC thesis |
| AMZN |
10 |
$198.79 |
$212.65 |
+$139 |
+7.0% |
|
| IGV |
35 |
$82.77 |
$85.72 |
+$103 |
+3.6% |
|
| WDAY |
36 |
$138.57 |
$142.49 |
+$141 |
+2.8% |
|
| CRM |
10 |
$189.97 |
$193.96 |
+$40 |
+2.1% |
|
| LOW |
16 |
$246.81 |
$246.81 |
$0 |
0.0% |
NEW today |
| ORCL |
25 |
$152.95 |
$149.40 |
-$89 |
-2.3% |
8.5% above stop -- CLOSEST |
yolo Positions (7) -- $99,191 (-0.81%)
| Stock |
Shares |
Entry |
Current |
P&L |
% |
Status |
| AVGO |
32 |
$313.78 |
$341.50 |
+$887 |
+8.8% |
Best by dollar P&L |
| WDAY |
72 |
$138.57 |
$142.49 |
+$282 |
+2.8% |
|
| TQQQ |
100 |
$48.78 |
$49.40 |
+$62 |
+1.3% |
Leveraged, flat |
| ARKK |
67 |
$74.36 |
$73.05 |
-$88 |
-1.8% |
Below entry |
| LOW |
40 |
$250.22 |
$246.81 |
-$136 |
-1.4% |
RSI 19.8 extreme |
| ORCL |
50 |
$152.95 |
$149.40 |
-$178 |
-2.3% |
Continued drift |
| CRSP |
100 |
$51.31 |
$49.94 |
-$137 |
-2.7% |
REVERSED from +14.6% |
bench-signals Top Movers (46 open signals, 6 closed)
Closed today: NFLX +20.0% (FIRST WIN!), AFRM -19.7% (5th loss).
Closed record: 1W / 5L. Realized: -$800 net (+$202 wins, -$1,002 losses).
New signals: MDT, DHR (life sciences tools entries).
Approaching stops: ESTC -12.1% (3.3% from -15%), PINS -12.0%.
7. Key Numbers
| Metric |
Value |
Context |
| Most Oversold (quality) |
BNTX RSI 23 |
mRNA capitulation. Needs research -- MRNA +89% 3M divergence. |
| Runner-up Oversold |
ITB RSI 27, MDT RSI 27 |
Housing capitulation + life sciences tools selloff. |
| Golden Signals |
ZERO |
Second consecutive scan. No RSI<30 + insider buying combo. |
| Best New Entry (acted) |
DHR RSI 29 + LOW RSI 30 |
Life sciences bellwether + only golden cross in oversold territory. |
| Most Overbought |
USO RSI 81 |
Oil parabolic. +55.9% 3M. Iran/Hormuz crisis. |
| Gold |
$476.25 (RSI 56) |
+21.1% 3M. Structural safe haven. Above all SMAs. |
| VIXY |
$32.68 (RSI 62) |
Down -4.1% 7D (slight easing) but +24.5% 30D. No all-clear. |
| VOO |
$622.00 (RSI 43) |
Slow bleed. -2.3% 30D. Below SMA20/SMA50. |
| Insider Posture |
49 selling, 3 buying |
Broadest bearish posture. TSLA +$191M, CRSP +$27M, ASAN +$8.3M only buyers. |
| Entry Zones Active |
23 |
0 extreme, 8 oversold, 15 approaching. |
| Signals (bench) |
52 total (46 open, 6 closed) |
1W/5L. First win! Net -$800 realized. |
| Best Strategy |
claude-trader +2.81% |
Leading since inception. |
| NFLX (bench WIN) |
+20.0% closed |
First winning signal! Held 28 days from $80.78 to $96.94. |
| SNOW (momentum) |
+14.3% |
Approaching +20% target ($188.05). 5% away. |
| Stagflation Signal |
USO +36.8% + COPX -7.8% + housing -14% |
Oil up, copper down, housing crushed = cost-push squeeze. |
| CRSP Reversal |
-11.6% 7D |
Was +14.6%, now -2.7%. Biggest single-position swing. |
8. What Changed (03/11 vs 03/10)
Stagflation regime intensified. Oil went parabolic (USO RSI 81, +36.8% 30D), crushing housing (ITB RSI 27), life sciences tools (DHR RSI 29, MDT RSI 27, TMO RSI 33), and consumer discretionary. This is no longer a "slow grind lower" -- it is a coordinated stagflation selloff driven by the Iran/Hormuz crisis.
CRSP reversed -11.6% in one week -- the biggest single-position swing across all strategies. Was +14.6% approaching +20% target, now -2.7%. YOLO was $1.97 from taking profit. Lesson forming: consider partial profit-taking at +15% on volatile positions.
bench-signals scored its FIRST WIN: NFLX +20.0%. After 5 consecutive losses (WDAY, MDB, HIMS, ASAN, AFRM), the signal tracker finally closed a winner. Held 28 days from $80.78 to $96.94. Record now 1W/5L, net -$800 realized. The system works -- it just needs time.
Life sciences tools entered coordinated selloff. DHR RSI 29, MDT RSI 27, TMO RSI 33, A RSI 31 -- all declining together in sector-wide de-rating. This is rare and historically a strong entry signal. Bought DHR across strategies. TMO (-8.9%) is now closest to stop in claude-trader.
Portfolio gave back gains across all strategies. Claude-trader dropped from +3.12% to +2.81%. YOLO from -0.33% to -0.81%. Momentum from -0.15% to -0.11% (actually slightly improved). Bench-signals from +1.8% open to -0.2% open. Broad market pullback.
Two new buys: DHR and LOW. DHR (RSI 29) is a rare extreme for a mega-cap quality compounder -- bought across trader, momentum, and bench-signals. LOW (RSI 30) is the ONLY oversold stock with golden cross intact -- bought across trader and momentum. Skipped NKE (death cross), BNTX (needs research), CRSP add (death cross).
ESTC and PINS approaching bench-signals stops. ESTC at -12.1% is only 3.3% from -15% stop. PINS at -12.0%. These could be the 6th and 7th losses if they don't stabilize. Meanwhile LEGN surged to +13.7% from RSI 8 capitulation -- the recovery thesis working on the biotech side.
Sources
Generated 2026-03-11 from validated daily summaries (summaries), portfolio files, and actions. Previous status archived.